Brinker Capital Investments’s Insmed INSM Stock Holding History

Brinker Capital Investments’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.78M	Buy	35,467 +826	+2%	+$100K	0.03%	490
2026 Q1	$5.66M	Sell	34,641 -1,945	-5%	-$299K	0.05%	335
2025 Q4	$6.37M	Sell	36,586 -107	-0.3%	-$19.5K	0.05%	347
2025 Q3	$5.28M	Sell	36,693 -5,124	-12%	-$628K	0.04%	410
2025 Q2	$4.21M	Buy	41,817 +3,082	+8%	+$236K	0.04%	459
2025 Q1	$2.96M	Buy	38,735 +10,973	+40%	+$839K	0.03%	538
2024 Q4	$1.92M	Sell	27,762 -325	-1%	-$23.4K	0.02%	725
2024 Q3	$2.05M	Buy	28,087 +9,170	+48%	+$677K	0.02%	675
2024 Q2	$1.27M	Buy	+18,917	New	+$734K	0.01%	872

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Brinker Capital Investments's INSM Position: Q2 2026 in Review

Brinker Capital Investments increased its Insmed (INSM) stake by 2.4% in Q2 2026, buying an estimated $100K and bringing the position to 35,467 shares worth $3.78M. The position accounts for 0.03% of the portfolio, ranked #490.

Brinker Capital Investments first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.37M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Brinker Capital Investments held 35,467 shares of Insmed worth $3.78M as of Q2 2026.
Brinker Capital Investments bought 826 Insmed shares in Q2 2026, an estimated $100K.
Insmed made up 0.03% of Brinker Capital Investments's portfolio in Q2 2026, its #490 holding.
Brinker Capital Investments first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
Brinker Capital Investments's Insmed position peaked at $6.37M in Q4 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.